EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Green Tea as Anti-Diabetic: Mechanisms, Epidemiological Evidence, and Clinical Potential

Rabyah Ali, Mustafa Almokhtar, Hana Kamoka

Libyan Journal of Medical Research · 21.07.2026 · 20 (2) · 434-448

DOI: 10.54361/ljmr.20.2.64 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Libyan Journal of Medical Research, online erschienen am 21.07.2026. Verfasst von Rabyah Ali und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus (DM) has reached epidemic proportions globally, necessitating the exploration of safe, cost-effective adjunctive therapies. Green tea (Camellia sinensis), particularly epigallocatechin-3-gallate (EGCG) and tea polysaccharides (TPS), has demonstrated significant antidiabetic potential across numerous experimental and clinical settings. This paper provides a comprehensive review of the multifaceted mechanisms through which green tea manages hyperglycemia. These include the potent inhibition of carbohydrate-digesting enzymes alpha-amylase and α-glucosidase, the enhancement of insulin sensitivity, and the protection of pancreatic β-cells from oxidative stress and inflammatory cytokine-induced damage. Some evidence suggests that green tea consumption effectively improves fasting blood glucose (FBG), glycated haemoglobin (HbA1c), and lipid profiles. While bioavailability and clinical inconsistencies remain challenges due to genetic polymorphisms and microbiota variations, green tea is generally considered safe for long-term consumption. In conclusion, green tea stands as a premier bio-functional beverage for the prevention and management of type 2 diabetes and its secondary complications. Future research should prioritize advanced delivery systems, such as nano-encapsulation, to maximise therapeutic outcomes.

Zitieren

APA

Ali, R., Almokhtar, M., & Kamoka, H. (2026). Green Tea as Anti-Diabetic: Mechanisms, Epidemiological Evidence, and Clinical Potential. Libyan Journal of Medical Research, 20(2), 434-448. https://doi.org/10.54361/ljmr.20.2.64

Vancouver

Ali R, Almokhtar M, Kamoka H. Green Tea as Anti-Diabetic: Mechanisms, Epidemiological Evidence, and Clinical Potential. Libyan Journal of Medical Research. 2026;20(2):434-448. doi:10.54361/ljmr.20.2.64

BibTeX
@article{Ali2026,
  author = {Ali, Rabyah and Almokhtar, Mustafa and Kamoka, Hana},
  title = {Green Tea as Anti-Diabetic: Mechanisms, Epidemiological Evidence, and Clinical Potential},
  journal = {Libyan Journal of Medical Research},
  year = {2026},
  volume = {20},
  number = {2},
  pages = {434--448},
  doi = {10.54361/ljmr.20.2.64}
}
Kostenlos starten →